← Leaderboards
Paul W. Burridge
Stanford University
$6,528,957
Attributed
$14,900,041
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,900,041 · 7
By mechanism
UM1$6,526,413 · 1
R01$6,046,255 · 3
R44$1,495,522 · 1
R00$742,924 · 1
K99$88,927 · 1
Top collaborators
- Yadav Sapkota8 shared
- Barbara E Stranger7 shared
- Mazhar Adli4 shared
- Feng Yue4 shared
- Alysson R. Muotri2 shared
- Steven D Rees2 shared
Most similar at Stanford University
Same institution · by research overlap
- Mark Mercola$44,191,191
- Joseph C Wu$80,370,369
- Daniel Bernstein$12,897,102
- Kathleen Lombard Poston$8,637,629
- Eben N Broadbent$174,999
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticGenesIn VitroDoseCardiac MyocytesPhenotypeBiologicalGenome Wide Association StudyPreventPredispositionGenetic VariantGenomePharmaceutical PreparationsCohortResponseCellsCardiotoxicityDoxorubicinModalityChemotherapyInterestComplicationHeart FailureMediating
Grant awards (25)
Molecular and cellular characterization of essential human genes.$1,612,686
UM1 · FY2025 · HG
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children$678,833
R01 · FY2025 · CA · contact PI
Mechanistic Insight to Predict and Prevent Nilotinib-Induced Artery Disease$645,460
R01 · FY2025 · CA · contact PI
Molecular and cellular characterization of essential human genes.$1,612,686
UM1 · FY2024 · HG
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children$678,833
R01 · FY2024 · CA · contact PI
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children$126,396
R01 · FY2024 · CA · contact PI
Predicting and Preventing Chemotherapy-InducedCardiotoxicity in African American Children$58,266
R01 · FY2024 · CA · contact PI
Molecular and cellular characterization of essential human genes.$1,631,251
UM1 · FY2023 · HG
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children$678,833
R01 · FY2023 · CA · contact PI
Molecular and cellular characterization of essential human genes.$1,669,790
UM1 · FY2022 · HG
HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs$735,163
R44 · FY2022 · GM
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children$665,257
R01 · FY2022 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$332,271
R01 · FY2022 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$75,013
R01 · FY2022 · CA · contact PI
HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs$760,359
R44 · FY2021 · GM
Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children$684,513
R01 · FY2021 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$339,052
R01 · FY2021 · CA · contact PI
Assessing the ability of hiCMs to recapitulate patient-specific doxorubicin-induced cardiotoxicity$76,544
R01 · FY2021 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$339,052
R01 · FY2020 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$328,880
R01 · FY2019 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$339,052
R01 · FY2018 · CA · contact PI
Modeling the role of the genome in chemotherapy induced cardiotoxicity using iPSC$246,273
R00 · FY2017 · HL · contact PI
Modeling the role of the genome in chemotherapy induced cardiotoxicity using iPSC$247,651
R00 · FY2016 · HL · contact PI
Modeling the role of the genome in chemotherapy induced cardiotoxicity using iPSC$249,000
R00 · FY2015 · HL · contact PI
Modeling the role of the genome in chemotherapy induced cardiotoxicity using iPSC$88,927
K99 · FY2014 · HL · contact PI